Oral alpha-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions.
about
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesAstaxanthin: a potential therapeutic agent in cardiovascular diseaseAstaxanthin, oxidative stress, inflammation and cardiovascular disease.Carotenoids: potential allies of cardiovascular health?The role of oxysterols in vascular ageing.Corosolic Acid Induces Non-Apoptotic Cell Death through Generation of Lipid Reactive Oxygen Species Production in Human Renal Carcinoma Caki Cells.
P2860
Oral alpha-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Oral alpha-tocopherol suppleme ...... human atherosclerotic lesions.
@en
type
label
Oral alpha-tocopherol suppleme ...... human atherosclerotic lesions.
@en
prefLabel
Oral alpha-tocopherol suppleme ...... human atherosclerotic lesions.
@en
P2093
P2860
P1476
Oral alpha-tocopherol suppleme ...... human atherosclerotic lesions
@en
P2093
Iain R Challis
Ian F Dennis
Malcolm J Mitchinson
Mark A Freeman
Peter J Kirkpatrick
Peter L Weissberg
P2860
P304
P356
10.1080/10715760310001604143
P577
2003-11-01T00:00:00Z